SCOTT DAVID J 4

Accession 0001127602-12-023284

CIK 0000318154other

View on SEC.gov Company Profile

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 8:00 PM ET

Size

31.9 KB

Accession

0001127602-12-023284

Insider Transaction Report

Form 4

Period: 2012-07-27

AMGEN INCAMGN

SCOTT DAVID J

Sr. VP, Gen. Counsel & Secy.

Transactions

Exercise/Conversion
Common Stock
2012-07-30$42.13/sh+20,000$842,600→ 129,058 total
Exercise/Conversion
Common Stock
2012-07-30$58.43/sh+20,000$1,168,600→ 179,058 total
Sale
Common Stock
2012-07-30$84.23/sh−20,000$1,684,660→ 115,558 total
Sale
Common Stock
2012-07-30$83.95/sh−30,000$2,518,620→ 85,558 total
Exercise/Conversion
Nqso (Right to Buy)
2012-07-30−20,000→ 0 total
Exercise: $42.13From: 2009-04-29Exp: 2015-04-29→ Common Stock (20,000 underlying)
Sale
Common Stock
2012-07-27$82.00/sh−30,000$2,460,000→ 65,558 total
Exercise/Conversion
Common Stock
2012-07-30$71.88/sh+1,391$99,985→ 66,949 total
Exercise/Conversion
Common Stock
2012-07-30$50.44/sh+30,000$1,513,200→ 159,058 total
Sale
Common Stock
2012-07-30$84.29/sh−1,391$117,243→ 177,667 total
Sale
Common Stock
2012-07-30$84.25/sh−42,109$3,547,515→ 135,558 total
Sale
Common Stock
2012-07-30$83.93/sh−20,000$1,678,540→ 65,558 total
Exercise/Conversion
Common Stock
2012-07-30$71.88/sh+42,109$3,026,795→ 109,058 total
Exercise/Conversion
Iso (Right to Buy)
2012-07-30−1,391→ 0 total
Exercise: $71.88From: 2010-04-03Exp: 2013-04-03→ Common Stock (1,391 underlying)
Exercise/Conversion
Nqso (Right to Buy)
2012-07-30−42,109→ 0 total
Exercise: $71.88From: 2007-04-03Exp: 2013-04-03→ Common Stock (42,109 underlying)
Exercise/Conversion
Nqso (Right to Buy)
2012-07-30−30,000→ 10,000 total
Exercise: $50.44From: 2010-04-28Exp: 2016-04-28→ Common Stock (30,000 underlying)
Exercise/Conversion
Nqso (Right to Buy)
2012-07-30−20,000→ 20,000 total
Exercise: $58.43From: 2011-04-26Exp: 2020-04-26→ Common Stock (20,000 underlying)

Footnotes (7)

[F1]The price reported is an average price. The prices ranged from $84.28 to $84.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
[F2]The price reported is an average price. The prices ranged from $84.23 to $84.28 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
[F3]The price reported is an average price. The prices ranged from $84.22 to $84.26 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
[F4]The price reported is an average price. The prices ranged from $83.90 to $84.03 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
[F5]The price reported is an average price. The prices ranged from $83.90 to $83.97 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
[F6]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; and 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
[F7]These shares include 31 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMGEN INC

CIK 0000318154

→

Entity typeother

Related Parties

filerCIK 0001145154

Filing Metadata

Form type: 4
Filed: Jul 30, 8:00 PM ET
Accepted: Jul 31, 8:00 PM ET
Size: 31.9 KB

View on SEC.gov